Clinical trials: Edema Brain
Traumatic Brain Injury, Cerebral Edema
Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury
The purpose of this study is to investigate the clinical improvement measured by the Glasgow Outcome Scale Extended (GOS-E) with ABX-101 compared with Placebo intramuscular injection in participants with moderate to severe TBI.
- Trial name
- NCT06096415
- Testing
- ABX-101 1mg, ABX-101 2mg
- Volunteers
- 45 people
- Sponsor
- Abalonex, LLC
Acute Ischemic Stroke
"The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"
The investigators need to test the effect of Trimetazidine on the pro-inflammatory marker Interleukin - 18 , NIHSS score, and mRs score of acute ischemic stroke patients.
- Trial name
- NCT06656442
- Testing
- Trimetazidine
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Ain Shams University
Cerebral Hemorrhage, Hypertensive, Intracranial Hypertension
Bleeding Intracerebral Hemorrhage With Early Invasive Intracranial Pressure Monitoring Trial
Spontaneous cerebral hemorrhage (SICH) is a hemorrhage caused by the rupture of a blood vessel within the brain parenchyma that is non-traumatic.
- Conditions
- Cerebral Hemorrhage, Hypertensive, Intracranial Hypertension, Monitoring, Critical Care
- Trial name
- BIATICH (NCT05593380)
- Testing
- Parenchymal Intracranial pressure monitor, Treatment based on clinical and imaging observations
- Where
- 17 sites in China
- Volunteers
- 193 people
- Sponsor
- Xiangya Hospital of Central South University
Intracerebral Hemorrhage
Association Between Haptoglobin Genotype and Brain Swelling
Intracerebral hemorrhage is bleeding into the brain and is a major cause of stroke and other complications. Brain injury from intracerebral hemorrhage occurs in two phases.
- Trial name
- NCT02054117
- Testing
- Intracerebral Hemorrhage
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- University of Florida
Heart Failure, Cardiomyopathies
Multimodal Physiologic State Intelligence Study
The OMNIPHYS study will investigate whether multimodal ultrasound and other routinely collected clinical and physiologic data can be combined with artificial intelligence to characterize changes in a person's physiologic state…
- Conditions
- Heart Failure, Cardiomyopathies, Pulmonary Hypertension, Myocarditis; Acute or Subacute
- Trial name
- OMNIPHYS (NCT07814118)
- Testing
- OMNIPHYS Multimodal Ultrasound Imaging System
- Where
- United States
- Volunteers
- 25,000 people, healthy volunteers welcome
- Sponsor
- Truway Health, Inc.